Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | Chief Commercial Officer | February 22, 2022 | February 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 22, 2022 · Filed February 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,103 |
Ending reported balance
After 2022-02-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2022-02-22 · Exercise / conversion · Acquired 1,531 · Balance 63,854 Row 2 · 2022-02-22 · Exercise / conversion · Acquired 2,391 · Balance 66,245 Row 3 · 2022-02-22 · Exercise / conversion · Acquired 2,598 · Balance 68,843 Row 4 · 2022-02-22 · Tax withholding · Disposed 3,740 · Balance 65,103 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,657 |
Reported balance
After 2022-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-22 · Exercise / conversion · Disposed 1,531 · Balance 7,657 F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,126 |
Reported balance
After 2022-02-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-22 · Exercise / conversion · Disposed 2,391 · Balance 19,126 F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,989 |
Reported balance
After 2022-02-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-22 · Exercise / conversion · Disposed 2,598 · Balance 12,989 F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F2: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F3: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
F4: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000056 · wf-form4_159018652325099.xml · derivative · entry 5 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,375 Underlying: Common Stock · 6,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 10,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000056 · wf-form4_159018652325099.xml · derivative · entry 4 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,173 Underlying: Common Stock · 10,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 7,763 | $4.39 | $34,040.76 |
DisclosureSEC source: 0001162194-20-000056 · wf-form4_159018652325099.xml · nonDerivative · entry 3 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,260 Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000056 · wf-form4_159018652325099.xml · nonDerivative · entry 2 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 10,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000056 · wf-form4_159018652325099.xml · nonDerivative · entry 1 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed Jun 5, 2020 19:55 UTC Amendment | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 6,797 | $4.39 | $29,804.85 |
DisclosureSEC source: 0001162194-20-000068 · wf-form4a_159138693503188.xml · nonDerivative · entry 1 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,226 F1 · shares: This amended Form 4 is being filed solely to report that the number of shares withheld for tax liability upon the vesting of RSU awards represented a disposition of 6,797 shares rather than 7,763 shares, as was reported on the Form 4 filed on May 22, 2020. All other information remains the same. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:34 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 38,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000023 · wf-form4_158405246048719.xml · derivative · entry 1 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,250 Underlying: Common Stock · 38,250 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 10,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000056 · wf-form4_156037514667617.xml · derivative · entry 3 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,391 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On March 30, 2019, the Reporting Person was granted 10,391 Restricted Stock Units, all of which vested on June 10, 2019. F2 · derivative.expiration_date: On March 30, 2019, the Reporting Person was granted 10,391 Restricted Stock Units, all of which vested on June 10, 2019. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 4,884 | $12.89 | $62,954.76 |
DisclosureSEC source: 0001162194-19-000056 · wf-form4_156037514667617.xml · nonDerivative · entry 2 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507 Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 10,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000056 · wf-form4_156037514667617.xml · nonDerivative · entry 1 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,391 Read SEC document |
| April 30, 2019 Filed May 2, 2019 21:28 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 24,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000030 · wf-form4_155683248371151.xml · derivative · entry 1 McCracken Colin · CIK 0001775380 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: 25% of the Restricted Stock Units vest on May 20, 2020, and the remaining Restricted Stock Units vest in twelve equal quarterly increments thereafter. F2 · derivative.expiration_date: 25% of the Restricted Stock Units vest on May 20, 2020, and the remaining Restricted Stock Units vest in twelve equal quarterly increments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.